WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

Series D

Ronovo Surgical raises $67M Series D led by J&J's venture arm

MedDevice Startups Staff · Sep 5 · 2 min read · Via MassDevice

Ronovo Surgical raised $67 million in a Series D led by JJDC, Johnson & Johnson's venture arm, announced September 5, 2025. Lilly Asia Ventures, INCE Capital and Granite Asia also invested. The Shanghai company, founded in 2019, has now raised more than $100 million across its Series C and Series D in about a year.

Carina is a modular laparoscopic surgical robot built from mobile patient-side carts rather than a single boom. China's NMPA approved it in March 2025 for general surgery, gynecology, urology and thoracic surgery. Alongside the round, Ronovo signed an agreement with Johnson & Johnson Medical Shanghai. The two will sell Carina with J&J MedTech surgical products to hospitals in parts of China. J&J's own Ottava robot is not yet submitted to FDA, so the deal gives its China sales force an approved robot today.

Questions & Answers

How much did Ronovo Surgical raise in its Series D?

Ronovo Surgical raised $67 million in a Series D led by JJDC, Johnson & Johnson's venture arm, announced September 5, 2025. Lilly Asia Ventures, INCE Capital and Granite Asia also participated.

Is the Ronovo Surgical Carina robot approved?

China's NMPA approved the Carina platform in March 2025 for general surgery, gynecology, urology and thoracic surgery. Carina does not have FDA clearance.

What is the Johnson & Johnson agreement with Ronovo Surgical?

Ronovo Surgical signed an agreement with Johnson & Johnson Medical Shanghai to sell Carina alongside J&J MedTech surgical products to hospitals in parts of China. It was announced with the $67 million Series D in September 2025.

← Back to Fundraising